In China, domestic trade in both tiger and rhinoceros products has been banned since 1993 and the maximum penalty for illicit trade is death. This report documents the progress made in implementing the ban but also the continuing availability of rhinoceros horn, tiger bone and their medicinal derivatives in the country.
A focus on the use of tiger bone as a medicinal, this review compiles what is known of the current status of tiger populations, the uses and value of tiger bone and the global extent of the trade. It gives recommendations for tiger conservation based on the report's findings.
